R Squared Ltd Makes New $251,000 Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

R Squared Ltd acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 481 shares of the medical equipment provider’s stock, valued at approximately $251,000.

Several other large investors have also modified their holdings of ISRG. Deane Retirement Strategies Inc. increased its position in Intuitive Surgical by 1.0% during the fourth quarter. Deane Retirement Strategies Inc. now owns 10,050 shares of the medical equipment provider’s stock worth $5,246,000 after purchasing an additional 97 shares during the last quarter. BSW Wealth Partners increased its holdings in shares of Intuitive Surgical by 6.1% during the 4th quarter. BSW Wealth Partners now owns 1,556 shares of the medical equipment provider’s stock worth $812,000 after buying an additional 90 shares during the last quarter. Bensler LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth $1,316,000. Perigon Wealth Management LLC boosted its holdings in Intuitive Surgical by 6.4% in the fourth quarter. Perigon Wealth Management LLC now owns 5,804 shares of the medical equipment provider’s stock valued at $3,029,000 after acquiring an additional 350 shares during the last quarter. Finally, Buffington Mohr McNeal grew its position in Intuitive Surgical by 6.5% during the fourth quarter. Buffington Mohr McNeal now owns 507 shares of the medical equipment provider’s stock valued at $265,000 after acquiring an additional 31 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 28,749 shares of company stock worth $15,303,875. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Robert W. Baird lifted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Citigroup boosted their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, Bernstein Bank raised their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $574.14 on Wednesday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a market capitalization of $204.50 billion, a P/E ratio of 92.31, a P/E/G ratio of 5.19 and a beta of 1.39. The company’s 50 day simple moving average is $548.00 and its 200 day simple moving average is $506.12.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.